Skip to main content

Sionna Therapeutics, Inc.

SION
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002036042

In the last 90 days, Sionna Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 146 institutions reported holding it in 13F filings for Q2 2026, worth $2.11B in total; Viking Global Investors is the only superinvestor holding it.

Q1 2026 vs. Q4 2025

How the institutions holding Sionna Therapeutics, Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of SION: Q4 2025 compared with Q1 2026
MeasureQ4 2025Of which not filed for Q1 2026Q1 2026Change
Holders1012122+23
Shares44.0M1.19M45.4M+2.65M (+6.2%)
Value$1.81B$48.9M$1.82B+$56.2M (+3.2%)

2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (32)

Institutions that held Sionna Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Sold out (9)

Institutions that held Sionna Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of SION in Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
SG Americas Securities, LLC10,691$440.0K
American Century Companies Inc6,180$254.2K
Dark Forest Capital Management LP5,991$246.5K
D. E. Shaw & Co., Inc.5,742$236.2K
ProShare Advisors LLC4,903$201.7K
Balyasny Asset Management LLC1,406$57.8K
Amalgamated Bank504$21.0K
Daiwa Securities Group Inc.149$6.00K
Aster Capital Management (DIFC) Ltd37$1.52K

Not filed for Q1 2026 yet (2)

Institutions that held Sionna Therapeutics, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SION in Q4 2025 that haven't filed for Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Vanguard Group Inc1,184,951$48.7M
CIBC Private Wealth Group, LLC4,500$185.1K